公开(公告)号：US12129368B2

公开(公告)日：2024-10-29

申请号：US17419275

申请日：2019-12-27

申请人： Dow Global Technologies LLC

发明人： Jeffrey C. Munro ,  Haiyang Yu ,  Hong Yang ,  Lixin Sun ,  Colin Li Pi Shan

IPC分类号： C08L23/16 ,  C07F3/06 ,  C07F5/06 ,  C08F2/38 ,  C08F210/02 ,  C08F210/06 ,  C08F210/14 ,  C08J9/10 ,  C08J9/14 ,  C08K5/00 ,  C08K5/14 ,  C08K5/3435 ,  C08K5/5419 ,  C08K5/5425 ,  C08L23/04 ,  C08L23/06 ,  C08L23/08 ,  C08L23/20 ,  H01L31/048 ,  C08F210/16 ,  C08K5/23

CPC分类号： C08L23/0815 ,  C07F3/06 ,  C07F5/062 ,  C08F2/38 ,  C08F210/02 ,  C08F210/06 ,  C08F210/14 ,  C08J9/103 ,  C08J9/14 ,  C08J9/142 ,  C08K5/0025 ,  C08K5/005 ,  C08K5/14 ,  C08K5/3435 ,  C08K5/5419 ,  C08K5/5425 ,  C08L23/16 ,  C08L23/20 ,  H01L31/0481 ,  C08F210/16 ,  C08J2203/04 ,  C08J2323/06 ,  C08J2323/14 ,  C08J2323/20 ,  C08J2353/00 ,  C08J2423/08 ,  C08J2423/14 ,  C08J2423/20 ,  C08K5/23 ,  C08L2203/14 ,  C08L2203/16 ,  C08L2203/202 ,  C08L2203/206 ,  C08L2205/025 ,  C08L2207/066 ,  C08L2312/08 ,  C08L2314/06

摘要： The present disclosure relates to unsaturated polyolefins and processes for preparing the same. The present disclosure further relates to curable formulations comprising the unsaturated polyolefins that show improved crosslinking.

公开(公告)号：US20240352268A1

公开(公告)日：2024-10-24

申请号：US18639624

申请日：2024-04-18

申请人： SAMSUNG ELECTRONICS CO., LTD. ,  HANSOL CHEMICAL CO., LTD.

发明人： Yeseul PARK ,  Dohyeong KIM ,  Somang KIM ,  Jaehong NOH ,  Sanghyun SOHN ,  Deahee LEE ,  Kyungnam KIM ,  Chunrae NAM ,  Gyucheol YOON ,  Sungmin HA

IPC分类号： C09D11/322 ,  C07F3/06 ,  C09D11/36 ,  C09D11/52 ,  H10K50/16 ,  H10K71/13

CPC分类号： C09D11/322 ,  C07F3/06 ,  C09D11/36 ,  C09D11/52 ,  H10K50/16 ,  H10K71/135

摘要： A metal oxide nanoparticle for inkjet printing, where the metal oxide nanoparticle is surface modified and is dispersible in a non-polar solvent; an electron transport layer-forming ink composition for inkjet printing including the same; a preparation method for the metal oxide nanoparticle; and a light-emitting device and a display that are prepared with the metal oxide nanoparticle.

公开(公告)号：US20240325337A1

公开(公告)日：2024-10-03

申请号：US18654403

申请日：2024-05-03

申请人： Probioticsmart, LLC

发明人： Daniel J. DuBourdieu ,  Rajiv Lall

IPC分类号： A61K31/315 ,  A23K10/16 ,  A23K20/111 ,  A23K20/20 ,  A23K50/75 ,  A23L33/00 ,  A23L33/105 ,  A23L33/16 ,  A61K31/192 ,  A61K31/198 ,  A61K31/353 ,  A61K31/385 ,  A61K31/7008 ,  A61K31/716 ,  A61K33/04 ,  A61K35/748 ,  A61P3/02 ,  A61P37/06 ,  A61P39/06 ,  C07F3/06

CPC分类号： A61K31/315 ,  A23K10/16 ,  A23K20/111 ,  A23K20/30 ,  A23K50/75 ,  A23L33/105 ,  A23L33/16 ,  A23L33/40 ,  A61K31/192 ,  A61K31/198 ,  A61K31/353 ,  A61K31/385 ,  A61K31/7008 ,  A61K31/716 ,  A61K33/04 ,  A61K35/748 ,  A61P3/02 ,  A61P37/06 ,  A61P39/06 ,  C07F3/06 ,  A23V2002/00

摘要： The invention is directed to tetrahydrocurcuminoid-metal complexes. The complexes can be included in compositions that further include additional nutraceutical antimicrobials, antioxidants, and immune boosters. The tetrahydrocurcuminoid-metal complexes can be administered to animals to increase animal health, reduce stress, reduce oxidative stress, maintain health, improve health, improve immunity, improve vaccination efficacy, increase feed conversion rate, decrease pro-inflammatory cytokine levels, or any combination thereof in an animal. The tetrahydrocurcuminoid-metal complexes of the invention exhibit enhanced bioavailability relative to the individual, non-complexed components.

公开(公告)号：US20240309022A1

公开(公告)日：2024-09-19

申请号：US18571305

申请日：2022-06-21

申请人： BASF SE

发明人： Barbara Nave ,  Stefan Marx ,  Maarten Staal ,  Stefanie Calde ,  Joachim Dickhaut ,  Uwe Thiel

IPC分类号： C07F3/06 ,  C01B37/00 ,  C05G3/90

CPC分类号： C07F3/06 ,  C01B37/00 ,  C05G3/90

摘要： The present invention relates to a metal-organic framework comprising (i) at least one metal M selected from the group consisting of Na, K, Ca, Mg, Zn, Fe, Mn, Cu, Al, Ni, and Mo in cationic form; and at least one substituted pyrazolate compound of formula (I). Further, the present invention relates to the use of the metal-organic framework of the invention and methods of applying the metal-organic framework of the invention for reducing nitrification. Moreover, the present invention relates to agrochemical mixtures and compositions comprising the metal-organic framework of the invention as well as to a method of treating a fertilizer comprising the application of a metal-organic framework of the invention.

公开(公告)号：US20240300981A1

公开(公告)日：2024-09-12

申请号：US18272244

申请日：2022-01-14

申请人： MERCK PATENT GMBH

发明人： Clemens Kuehn

IPC分类号： C07F3/06 ,  G01N23/20

CPC分类号： C07F3/06 ,  G01N23/20 ,  G01N2223/604

摘要： The present invention is directed to solvated crystalline polynuclear metal complexes which solvation is with a polar solvent or a mixture of polar and non-polar solvent. These polar solvated crystalline metal complexes of the present invention can absorb an analyte guest compound, including an polar analyte guest compound, to form a crystal structure analysis sample. The molecular structure of the analyte guest compound can be determined by X-ray crystallography using the crystal structure analysis sample obtained with such solvated crystalline polynuclear metal complexes.

公开(公告)号：US12077551B2

公开(公告)日：2024-09-03

申请号：US17270384

申请日：2019-08-22

申请人： OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “Z THERAPEUTICS”

发明人： Vladimir Evgenievich Nebolsin

IPC分类号： C07F3/06 ,  A61P17/00

CPC分类号： C07F3/06 ,  A61P17/00

摘要： The invention relates to a new zinc complex with gamma-L-glutamylhistamine with a metal/ligand ratio of 1/1. In particular, the invention relates to a compound of the formula




The complex according to the invention helps to restore the barrier functions of the epithelial tissue and suppresses the aberrant activity of the immune cells.
The invention also relates to the method of complex preparation and use of said zinc complex for the treatment of atopic dermatitis and other diseases associated with impaired barrier functions of epithelial tissue and the development of an aberrant inflammatory response.
The invention also relates to the use of the prepared complex for inhibiting glutaminyl cyclase.
This invention also concerns pharmaceutical compositions comprising a therapeutically effective amount of a compound of the invention.

公开(公告)号：US12031014B2

公开(公告)日：2024-07-09

申请号：US16640202

申请日：2018-08-22

申请人： SEKISUI CHEMICAL CO., LTD.

发明人： Atsushi Ikoma ,  Shigeki Nomura ,  Rasika Dasanayake Aluthge

IPC分类号： C08K5/56 ,  B27N3/00 ,  B32B3/00 ,  C07F3/06 ,  C08K5/09 ,  C08K5/10

CPC分类号： C08K5/56 ,  B27N3/00 ,  B32B3/00 ,  C07F3/06 ,  C08K5/09 ,  C08K5/10

摘要： A composition comprising: a substance (A) comprising at least one metal atom selected from the group consisting of zinc, cobalt, niobium, zirconium, cadmium, copper, nickel, chromium, vanadium, titanium, molybdenum, magnesium, iron and aluminum, with the proviso that a metal organic framework is excluded; an organic substance (B) having at least two metal coordination sites capable of being coordinated to the metal atom to form a crystal, wherein the metal coordination sites are of at least one type selected from the group consisting of a carboxy group and a metal organic framework; and a coordination promoter (C) that undergoes a reaction or a phase transition upon stimulation to promote the coordination of the metal coordination sites of the organic substance (B) to the metal atom of the substance (A).

公开(公告)号：US20240215437A1

公开(公告)日：2024-06-27

申请号：US18501365

申请日：2023-11-03

申请人： Samsung Display Co., LTD.

发明人： CHUL SOON PARK ,  WON-JUN PARK ,  JONGWOO SHIN ,  Yun Ku JUNG

IPC分类号： H10K85/30 ,  C07F3/06

CPC分类号： H10K85/381 ,  C07F3/06 ,  H10K50/16

摘要： According to an embodiment, the inorganic metal oxide includes a crystalline core and a ligand positioned on a surface of the crystalline core, the crystalline core includes crystalline ZnO, and the ligand is a compound represented by Formula 1 below. In Chemical Formula 1, n may indicate 1 or 3, and X may indicate one selected from SH, an amine, methoxysilane, a carboxylic acid, and a carbonyl acid.

公开(公告)号：US12022672B2

公开(公告)日：2024-06-25

申请号：US17881878

申请日：2022-08-05

申请人： Novaled GmbH

发明人： Ulrich Heggemann ,  Markus Hummert

IPC分类号： H01L51/50 ,  C07F3/02 ,  C07F3/06 ,  C07F5/02 ,  C09K11/06 ,  H10K50/155 ,  H10K50/17 ,  H10K59/35 ,  H10K71/00 ,  H10K71/30 ,  H10K85/30 ,  H10K85/60 ,  H10K30/30 ,  H10K50/11 ,  H10K50/16 ,  H10K50/165 ,  H10K50/18 ,  H10K71/16 ,  H10K102/10

CPC分类号： H10K50/155 ,  C07F3/02 ,  C07F3/06 ,  C07F5/022 ,  C09K11/06 ,  H10K50/171 ,  H10K59/35 ,  H10K71/00 ,  H10K71/30 ,  H10K85/30 ,  H10K85/322 ,  H10K85/341 ,  H10K85/381 ,  H10K85/60 ,  H10K85/622 ,  H10K85/633 ,  H10K85/636 ,  H10K85/657 ,  H10K85/6572 ,  C09K2211/1018 ,  H10K30/30 ,  H10K50/11 ,  H10K50/16 ,  H10K50/165 ,  H10K50/17 ,  H10K50/18 ,  H10K71/164 ,  H10K85/615 ,  H10K2102/103

摘要： The present invention relates to an electronic device comprising between a first electrode and a second electrode at least one first semiconducting layer comprising



(i) at least one first hole transport matrix compound consisting of covalently bound atoms and
(ii) at least one electrical p-dopant selected from metal borate complexes, wherein the metal borate complex consists of at least one metal cation and at least one anionic ligand consisting of at least six covalently bound atoms which comprises at least one boron atom,

wherein the first semiconducting layer is a hole injection layer, a hole-injecting part of a charge generating layer or a hole transport layer, a method for preparing the same and a respective metal borate compound.

公开(公告)号：US11976087B2

公开(公告)日：2024-05-07

申请号：US18026820

申请日：2022-02-15

申请人： SOOCHOW UNIVERSITY

发明人： Jianping Lang ,  Zhanyong Yang ,  Chunyan Ni

IPC分类号： C07F3/06 ,  C08J5/18 ,  C08K5/00 ,  F03G7/00

CPC分类号： C07F3/06 ,  C08J5/18 ,  C08K5/0091 ,  F03G7/016 ,  F03G7/029 ,  C08J2329/04

摘要： The invention provides a light-stimuli responsive coordination polymer, and preparation method and use thereof. The coordination polymer has a chemical formula of [Zn(tkpvb) (Fb)2]n1, wherein Fb represents p-fluorobenzoate, tkpvb represents 1,2,4,5-tetrakis((E)-2-(4-pyridyl)vinyl)benzene, and n=3000-60000; and crystallographic parameters of: (1) crystal system: monoclinic system; (2) space group: C2/c; (3) a=28.577(3)Å, b=7.4084(6) Å, c=22.612(3) Å, β=126.771(2)°, and V=3834.8(7) Å3; (4) Z=4; and (5) F(000)=1720, R1=0.0440, wR2=0.1042, and GOF=1.047. The method is simple, and has mild reaction conditions, and fast light conversion rate. The means of light-stimuli responsiveness are non-contact and non-damage type, the volume adjustment is highly accurate, and the whole adjustment process does not require any chemical reagents, and is safe and reliable. Photoactuators can complete a variety of behaviors under the irradiation of ultraviolet light having a wavelength of 365 nm.